<DOC>
	<DOCNO>NCT02391272</DOCNO>
	<brief_summary>The project undertake Qilu Hospital Shandong University well-known hospital China . Aims evaluate efficacy safety rhTPO management ITP pregnancy .</brief_summary>
	<brief_title>A Multicenter Study Recombinant Human Thrombopoietin Management ITP Pregnancy</brief_title>
	<detailed_description>The investigator undertake multicenter , open-labeled , pilot study 30 ITP patient pregnancy Qilu Hospital Shandong University well-known hospital China . ITP patient pregnancy fail respond prednisone , IVIG develop refractoriness platelet transfusion give rhTPO intravenously dose 300U/kg every day . Dose taper 300U/kg every day platelet count rise 50×10^9/L . Maintenance continue delivery dose reduce 300U/kg per week . Platelet count , bleed symptom evaluate treatment . Adverse event record throughout study .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic , Idiopathic</mesh_term>
	<criteria>1 . Subject 1850 year old . 2 . After 12 week gestation . 3 . Diagnosed ITP meeting diagnostic criterion immune thrombocytopenia . 4 . Patients response relapse Corticosteroid IVIG . 5 . Patients develop refractoriness platelet transfusion . 6 . To show platelet count &lt; 30×10^9/L , bleed manifestation . 7 . Willing able sign write informed consent . 1 . Received chemotherapy anticoagulant drug affect platelet count within 3 month screen visit . 2 . Received secondline ITPspecific treatment ( eg , cyclophosphamide , 6mercaptopurine , vincristine , vinblastine , etc ) within 3 month screen visit . 3 . Current HIV infection hepatitis B virus hepatitis C virus infection . 4 . Severe medical condition ( lung , hepatic renal disorder ) chronic ITP . Unstable uncontrolled disease condition relate impacting cardiac function ( e.g. , unstable angina , congestive heart failure , uncontrolled hypertension cardiac arrhythmia ) 5 . Have know diagnosis autoimmune disease , establish medical history laboratory finding positive result determination antinuclear antibody , anticardiolipin antibody , lupus anticoagulant direct Coombs test . 6 . Patients deem unsuitable study investigator .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>recombinant human thrombopoietin</keyword>
	<keyword>immune thrombocytopenia</keyword>
	<keyword>pregnancy</keyword>
</DOC>